By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AcelRx Pharmaceuticals 

575 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-216-3500 Fax: 650-216-6500




Company News
AcelRx (ACRX) To Present At Piper Jaffray 27th Annual Healthcare Conference 11/23/2015 7:35:59 AM
AcelRx (ACRX) Announces Sublingual Sufentanil Data Presentation At The American Society Of Regional Anesthesia And Pain Medicine Meeting 11/19/2015 7:19:14 AM
AcelRx (ACRX) To Present At Jefferies and Co. 2015 Global Healthcare Conference 11/10/2015 8:46:50 AM
AcelRx (ACRX) To Present At Credit Suisse 24th Annual Healthcare Conference 11/5/2015 11:02:16 AM
AcelRx (ACRX) Presents Data From Phase 3 Clinical Trials Evaluating The Safety And Efficacy Of Zalviso In Obese Surgical Patients 11/4/2015 6:24:25 AM
AcelRx (ACRX) Provides Business Update And Reports Third Quarter And Nine Months 2015 Financial Results 10/30/2015 6:32:42 AM
AcelRx (ACRX) To Hold Business Update And Third Quarter Financial Results Conference Call And Webcast On Thursday, Oct 29th, 2015 10/26/2015 10:43:38 AM
AcelRx (ACRX) Announces Presentation Of Phase 3 Data From ARX-04 Sufentanil Sublingual 30 mcg Program At The American Society Of Anesthesiology Meeting 10/23/2015 7:39:25 AM
AcelRx (ACRX) Announces Presentation Of Phase 3 Sufentanil Sublingual 30mcg Tablet Data At The European Society Of Emergency Medicine Meeting 10/9/2015 6:15:35 AM
AcelRx (ACRX) Provides Regulatory Update On Zalviso 10/8/2015 7:44:00 AM